| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypoplastic Left Heart Syndrome | 47 | 2023 | 77 | 9.360 |
Why?
|
| Heart Defects, Congenital | 54 | 2023 | 363 | 8.170 |
Why?
|
| Norwood Procedures | 27 | 2023 | 40 | 7.420 |
Why?
|
| Cardiac Surgical Procedures | 54 | 2022 | 474 | 5.780 |
Why?
|
| Palliative Care | 26 | 2022 | 263 | 3.570 |
Why?
|
| Monitoring, Physiologic | 15 | 2020 | 266 | 2.870 |
Why?
|
| Heart Ventricles | 20 | 2021 | 779 | 2.820 |
Why?
|
| Infant, Newborn | 74 | 2022 | 2473 | 2.390 |
Why?
|
| Oximetry | 17 | 2022 | 82 | 2.270 |
Why?
|
| Oxygen | 18 | 2022 | 742 | 2.190 |
Why?
|
| Spectroscopy, Near-Infrared | 12 | 2016 | 35 | 2.190 |
Why?
|
| Home Care Services, Hospital-Based | 5 | 2014 | 10 | 1.950 |
Why?
|
| Infant | 62 | 2023 | 3141 | 1.890 |
Why?
|
| Child Development | 12 | 2020 | 166 | 1.800 |
Why?
|
| Postoperative Complications | 26 | 2022 | 2273 | 1.530 |
Why?
|
| Blalock-Taussig Procedure | 9 | 2021 | 12 | 1.450 |
Why?
|
| Heart Bypass, Right | 7 | 2015 | 12 | 1.440 |
Why?
|
| Monitoring, Ambulatory | 4 | 2014 | 32 | 1.390 |
Why?
|
| Risk Factors | 48 | 2023 | 5463 | 1.390 |
Why?
|
| Heart-Assist Devices | 8 | 2021 | 755 | 1.360 |
Why?
|
| Fontan Procedure | 11 | 2019 | 56 | 1.280 |
Why?
|
| Child | 46 | 2023 | 7139 | 1.200 |
Why?
|
| Pulmonary Artery | 14 | 2021 | 319 | 1.170 |
Why?
|
| Hemodynamics | 15 | 2021 | 729 | 1.140 |
Why?
|
| Developmental Disabilities | 7 | 2020 | 202 | 1.130 |
Why?
|
| Critical Care | 14 | 2022 | 380 | 1.130 |
Why?
|
| Registries | 11 | 2023 | 778 | 1.090 |
Why?
|
| Humans | 144 | 2023 | 88946 | 1.000 |
Why?
|
| Treatment Outcome | 47 | 2022 | 8188 | 1.000 |
Why?
|
| Preoperative Care | 5 | 2014 | 396 | 0.990 |
Why?
|
| Retrospective Studies | 44 | 2023 | 8990 | 0.990 |
Why?
|
| Consensus | 4 | 2019 | 356 | 0.970 |
Why?
|
| Respiration, Artificial | 7 | 2019 | 353 | 0.930 |
Why?
|
| Child, Preschool | 32 | 2021 | 3708 | 0.930 |
Why?
|
| Nutritional Support | 2 | 2014 | 16 | 0.870 |
Why?
|
| Substance Withdrawal Syndrome | 2 | 2022 | 46 | 0.870 |
Why?
|
| Gastrostomy | 3 | 2018 | 69 | 0.860 |
Why?
|
| Time Factors | 31 | 2020 | 5318 | 0.790 |
Why?
|
| Postoperative Care | 6 | 2019 | 229 | 0.790 |
Why?
|
| Critical Illness | 3 | 2016 | 307 | 0.790 |
Why?
|
| Heart Transplantation | 7 | 2020 | 715 | 0.780 |
Why?
|
| Weight Gain | 3 | 2020 | 119 | 0.720 |
Why?
|
| Nervous System | 4 | 2019 | 89 | 0.720 |
Why?
|
| Hospital Mortality | 15 | 2020 | 386 | 0.700 |
Why?
|
| Abnormalities, Multiple | 2 | 2019 | 234 | 0.700 |
Why?
|
| Male | 73 | 2021 | 42191 | 0.690 |
Why?
|
| Turner Syndrome | 1 | 2019 | 27 | 0.690 |
Why?
|
| Health Resources | 3 | 2017 | 81 | 0.680 |
Why?
|
| Life Support Care | 1 | 2019 | 50 | 0.670 |
Why?
|
| Female | 71 | 2021 | 45954 | 0.670 |
Why?
|
| Continuity of Patient Care | 3 | 2012 | 172 | 0.640 |
Why?
|
| Intensive Care Units, Pediatric | 8 | 2019 | 104 | 0.630 |
Why?
|
| Attitude to Health | 1 | 2019 | 222 | 0.620 |
Why?
|
| Enteral Nutrition | 4 | 2020 | 102 | 0.620 |
Why?
|
| Cerebrovascular Circulation | 6 | 2021 | 227 | 0.620 |
Why?
|
| Patient Care Team | 2 | 2020 | 283 | 0.610 |
Why?
|
| Follow-Up Studies | 23 | 2021 | 3655 | 0.610 |
Why?
|
| Family | 1 | 2019 | 325 | 0.600 |
Why?
|
| Child Behavior | 2 | 2019 | 47 | 0.590 |
Why?
|
| Pulmonary Circulation | 6 | 2022 | 90 | 0.580 |
Why?
|
| Cardiopulmonary Bypass | 7 | 2020 | 157 | 0.580 |
Why?
|
| Patient Readmission | 2 | 2021 | 351 | 0.570 |
Why?
|
| Heart Failure | 5 | 2021 | 1176 | 0.560 |
Why?
|
| Wisconsin | 9 | 2019 | 41 | 0.560 |
Why?
|
| Length of Stay | 15 | 2022 | 733 | 0.540 |
Why?
|
| Quality Improvement | 8 | 2023 | 447 | 0.530 |
Why?
|
| Alprostadil | 2 | 2014 | 25 | 0.530 |
Why?
|
| Vasodilator Agents | 2 | 2014 | 146 | 0.520 |
Why?
|
| Incidence | 10 | 2021 | 1591 | 0.510 |
Why?
|
| Cardiac Catheterization | 7 | 2019 | 302 | 0.500 |
Why?
|
| Health Care Costs | 1 | 2017 | 235 | 0.500 |
Why?
|
| Quality Assurance, Health Care | 3 | 2017 | 225 | 0.490 |
Why?
|
| Risk Assessment | 16 | 2019 | 2289 | 0.480 |
Why?
|
| Vasoconstrictor Agents | 1 | 2014 | 56 | 0.480 |
Why?
|
| Cardiotonic Agents | 1 | 2014 | 89 | 0.470 |
Why?
|
| Cardiology | 3 | 2023 | 114 | 0.450 |
Why?
|
| Chronic Disease | 1 | 2017 | 948 | 0.450 |
Why?
|
| Prospective Studies | 20 | 2022 | 4265 | 0.450 |
Why?
|
| Postoperative Period | 9 | 2021 | 301 | 0.450 |
Why?
|
| Nutritional Status | 2 | 2023 | 80 | 0.440 |
Why?
|
| Pediatrics | 4 | 2022 | 352 | 0.440 |
Why?
|
| Aortic Valve Stenosis | 1 | 2014 | 143 | 0.430 |
Why?
|
| Cognition | 4 | 2019 | 579 | 0.430 |
Why?
|
| Databases, Factual | 5 | 2018 | 850 | 0.420 |
Why?
|
| Intracranial Hemorrhages | 1 | 2013 | 129 | 0.420 |
Why?
|
| Failure to Thrive | 1 | 2012 | 17 | 0.410 |
Why?
|
| Patient Discharge | 5 | 2021 | 320 | 0.410 |
Why?
|
| Aprotinin | 3 | 2009 | 26 | 0.410 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2013 | 52 | 0.410 |
Why?
|
| Cause of Death | 3 | 2019 | 266 | 0.410 |
Why?
|
| Societies, Medical | 3 | 2016 | 567 | 0.410 |
Why?
|
| Transposition of Great Vessels | 4 | 2017 | 24 | 0.410 |
Why?
|
| Motor Activity | 2 | 2019 | 327 | 0.400 |
Why?
|
| Stroke | 1 | 2021 | 982 | 0.400 |
Why?
|
| Attention | 2 | 2013 | 393 | 0.390 |
Why?
|
| United States | 19 | 2022 | 6942 | 0.390 |
Why?
|
| Drug Hypersensitivity | 2 | 2009 | 37 | 0.390 |
Why?
|
| Hemostatics | 2 | 2009 | 57 | 0.380 |
Why?
|
| Vascular Resistance | 6 | 2019 | 101 | 0.360 |
Why?
|
| Thoracic Surgery | 2 | 2021 | 44 | 0.360 |
Why?
|
| Extracorporeal Membrane Oxygenation | 8 | 2019 | 181 | 0.360 |
Why?
|
| Heart Diseases | 4 | 2019 | 298 | 0.350 |
Why?
|
| Intraoperative Care | 2 | 2009 | 84 | 0.350 |
Why?
|
| Survival Rate | 10 | 2019 | 1884 | 0.340 |
Why?
|
| Intraoperative Complications | 3 | 2017 | 188 | 0.340 |
Why?
|
| Ventilator Weaning | 1 | 2008 | 24 | 0.320 |
Why?
|
| Perioperative Care | 5 | 2015 | 169 | 0.320 |
Why?
|
| Adolescent | 16 | 2021 | 9226 | 0.320 |
Why?
|
| Cardiac Output | 3 | 2019 | 156 | 0.310 |
Why?
|
| Hemoglobins | 2 | 2022 | 192 | 0.290 |
Why?
|
| Intensive Care Units | 5 | 2019 | 396 | 0.290 |
Why?
|
| Gastrointestinal Diseases | 1 | 2008 | 150 | 0.290 |
Why?
|
| Oxygen Consumption | 3 | 2022 | 243 | 0.290 |
Why?
|
| Multivariate Analysis | 7 | 2015 | 987 | 0.280 |
Why?
|
| Respiratory Insufficiency | 1 | 2008 | 161 | 0.280 |
Why?
|
| Infant Mortality | 4 | 2021 | 59 | 0.280 |
Why?
|
| Anticoagulants | 4 | 2015 | 426 | 0.270 |
Why?
|
| Cooperative Behavior | 2 | 2019 | 179 | 0.270 |
Why?
|
| Gestational Age | 4 | 2020 | 323 | 0.270 |
Why?
|
| Aorta | 2 | 2006 | 286 | 0.260 |
Why?
|
| Kaplan-Meier Estimate | 6 | 2018 | 859 | 0.260 |
Why?
|
| Hospitals, Pediatric | 4 | 2021 | 114 | 0.260 |
Why?
|
| Morbidity | 6 | 2021 | 149 | 0.250 |
Why?
|
| Cardiac Output, Low | 3 | 2020 | 14 | 0.250 |
Why?
|
| Age Factors | 8 | 2021 | 1864 | 0.250 |
Why?
|
| Body Weight | 3 | 2013 | 452 | 0.250 |
Why?
|
| Brain Ischemia | 2 | 2006 | 399 | 0.240 |
Why?
|
| Trachea | 2 | 2017 | 291 | 0.240 |
Why?
|
| Home Nursing | 2 | 2020 | 19 | 0.240 |
Why?
|
| Logistic Models | 7 | 2019 | 1212 | 0.230 |
Why?
|
| Reoperation | 5 | 2020 | 598 | 0.230 |
Why?
|
| Kidney Diseases | 2 | 2021 | 319 | 0.220 |
Why?
|
| Chi-Square Distribution | 3 | 2013 | 360 | 0.210 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 3 | 2012 | 91 | 0.210 |
Why?
|
| Neuropsychological Tests | 3 | 2014 | 505 | 0.210 |
Why?
|
| Malnutrition | 1 | 2023 | 32 | 0.210 |
Why?
|
| Physicians | 2 | 2022 | 689 | 0.200 |
Why?
|
| Methadone | 1 | 2022 | 46 | 0.200 |
Why?
|
| Prognosis | 6 | 2019 | 3770 | 0.190 |
Why?
|
| Brain Chemistry | 1 | 2021 | 122 | 0.190 |
Why?
|
| Analgesics, Opioid | 2 | 2022 | 442 | 0.190 |
Why?
|
| Vasomotor System | 1 | 2001 | 13 | 0.190 |
Why?
|
| Linear Models | 2 | 2013 | 421 | 0.190 |
Why?
|
| Hospitalization | 4 | 2022 | 876 | 0.190 |
Why?
|
| Anastomosis, Surgical | 5 | 2017 | 273 | 0.190 |
Why?
|
| Thoracic Surgical Procedures | 2 | 2017 | 55 | 0.190 |
Why?
|
| Morphine | 1 | 2022 | 130 | 0.190 |
Why?
|
| Down Syndrome | 1 | 2020 | 55 | 0.180 |
Why?
|
| North America | 4 | 2013 | 184 | 0.180 |
Why?
|
| Regression Analysis | 4 | 2019 | 590 | 0.170 |
Why?
|
| Models, Theoretical | 1 | 2022 | 491 | 0.170 |
Why?
|
| Cohort Studies | 8 | 2019 | 2857 | 0.170 |
Why?
|
| Health Information Systems | 1 | 2019 | 2 | 0.170 |
Why?
|
| Animals, Newborn | 1 | 2001 | 524 | 0.170 |
Why?
|
| Bioethical Issues | 1 | 2019 | 38 | 0.170 |
Why?
|
| Vasopressins | 1 | 2019 | 50 | 0.170 |
Why?
|
| Chest Tubes | 1 | 2019 | 23 | 0.170 |
Why?
|
| Risk Adjustment | 1 | 2019 | 38 | 0.160 |
Why?
|
| Birth Weight | 1 | 2019 | 145 | 0.160 |
Why?
|
| Probability | 4 | 2009 | 353 | 0.160 |
Why?
|
| Atrioventricular Block | 1 | 2018 | 24 | 0.160 |
Why?
|
| Patient Care | 1 | 2019 | 102 | 0.160 |
Why?
|
| Renal Dialysis | 1 | 2021 | 335 | 0.160 |
Why?
|
| Anaerobic Threshold | 3 | 2010 | 4 | 0.160 |
Why?
|
| Ventricular Function | 3 | 2013 | 53 | 0.160 |
Why?
|
| Drainage | 1 | 2019 | 162 | 0.150 |
Why?
|
| Heart | 1 | 2021 | 573 | 0.150 |
Why?
|
| Predictive Value of Tests | 4 | 2019 | 1715 | 0.150 |
Why?
|
| Decision Support Techniques | 1 | 2019 | 167 | 0.150 |
Why?
|
| Device Removal | 1 | 2019 | 167 | 0.150 |
Why?
|
| Multicenter Studies as Topic | 3 | 2013 | 155 | 0.150 |
Why?
|
| Quality of Health Care | 2 | 2019 | 385 | 0.140 |
Why?
|
| Kidney Failure, Chronic | 1 | 2021 | 413 | 0.140 |
Why?
|
| Bronchial Diseases | 1 | 2017 | 12 | 0.140 |
Why?
|
| Tracheal Stenosis | 1 | 2017 | 23 | 0.140 |
Why?
|
| Hematocrit | 1 | 2016 | 68 | 0.140 |
Why?
|
| Comorbidity | 2 | 2019 | 947 | 0.140 |
Why?
|
| Recovery of Function | 2 | 2018 | 292 | 0.140 |
Why?
|
| Heterotaxy Syndrome | 1 | 2016 | 2 | 0.140 |
Why?
|
| Vascular System Injuries | 1 | 2017 | 30 | 0.140 |
Why?
|
| Microsurgery | 1 | 2017 | 88 | 0.140 |
Why?
|
| Constriction, Pathologic | 1 | 2017 | 217 | 0.140 |
Why?
|
| Coronary Care Units | 1 | 2016 | 4 | 0.130 |
Why?
|
| Referral and Consultation | 1 | 2019 | 341 | 0.130 |
Why?
|
| Antithrombin III | 1 | 2015 | 9 | 0.130 |
Why?
|
| Bronchi | 1 | 2017 | 229 | 0.130 |
Why?
|
| Survival Analysis | 7 | 2012 | 1533 | 0.130 |
Why?
|
| Bacteremia | 1 | 2016 | 102 | 0.130 |
Why?
|
| Postoperative Hemorrhage | 1 | 2015 | 46 | 0.130 |
Why?
|
| Blood Coagulation | 1 | 2015 | 92 | 0.130 |
Why?
|
| Fellowships and Scholarships | 1 | 2016 | 120 | 0.130 |
Why?
|
| Spleen | 1 | 2016 | 431 | 0.130 |
Why?
|
| Fetal Growth Retardation | 1 | 2015 | 67 | 0.130 |
Why?
|
| Congresses as Topic | 1 | 2016 | 112 | 0.130 |
Why?
|
| Treatment Failure | 3 | 2014 | 287 | 0.120 |
Why?
|
| Balloon Valvuloplasty | 1 | 2014 | 8 | 0.120 |
Why?
|
| Education, Medical, Continuing | 1 | 2016 | 105 | 0.120 |
Why?
|
| Apolipoprotein E2 | 1 | 2014 | 3 | 0.120 |
Why?
|
| Bacterial Infections | 1 | 2016 | 184 | 0.120 |
Why?
|
| Proportional Hazards Models | 5 | 2018 | 848 | 0.120 |
Why?
|
| Tracheobronchomalacia | 1 | 2014 | 11 | 0.120 |
Why?
|
| Odds Ratio | 2 | 2016 | 684 | 0.120 |
Why?
|
| S100 Calcium Binding Protein beta Subunit | 1 | 2014 | 4 | 0.120 |
Why?
|
| Vocal Cord Paralysis | 1 | 2014 | 27 | 0.120 |
Why?
|
| Enalapril | 2 | 2011 | 13 | 0.120 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2014 | 40 | 0.120 |
Why?
|
| Organ Dysfunction Scores | 1 | 2014 | 27 | 0.110 |
Why?
|
| Phenoxybenzamine | 3 | 2004 | 15 | 0.110 |
Why?
|
| Energy Intake | 1 | 2014 | 97 | 0.110 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2013 | 21 | 0.110 |
Why?
|
| Young Adult | 4 | 2017 | 6280 | 0.110 |
Why?
|
| Databases as Topic | 2 | 2010 | 94 | 0.110 |
Why?
|
| Child Language | 1 | 2013 | 6 | 0.110 |
Why?
|
| Truncus Arteriosus, Persistent | 1 | 2012 | 6 | 0.110 |
Why?
|
| Hypoxia | 4 | 2012 | 650 | 0.110 |
Why?
|
| Vena Cava, Superior | 4 | 2007 | 60 | 0.110 |
Why?
|
| Stress, Psychological | 2 | 2013 | 321 | 0.110 |
Why?
|
| Heart Arrest | 1 | 2016 | 279 | 0.110 |
Why?
|
| Growth | 1 | 2012 | 43 | 0.110 |
Why?
|
| Nonlinear Dynamics | 1 | 2013 | 73 | 0.110 |
Why?
|
| Double-Blind Method | 5 | 2019 | 1714 | 0.100 |
Why?
|
| Pituitary-Adrenal System | 1 | 2012 | 64 | 0.100 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2012 | 81 | 0.100 |
Why?
|
| Kidney | 2 | 2010 | 1145 | 0.100 |
Why?
|
| Skin Tests | 2 | 2009 | 44 | 0.100 |
Why?
|
| Brain | 2 | 2014 | 2270 | 0.100 |
Why?
|
| Heparin | 2 | 2015 | 185 | 0.100 |
Why?
|
| Cyanosis | 2 | 2012 | 9 | 0.100 |
Why?
|
| Saliva | 1 | 2012 | 123 | 0.100 |
Why?
|
| Adult | 8 | 2021 | 26473 | 0.100 |
Why?
|
| Echocardiography | 3 | 2021 | 937 | 0.100 |
Why?
|
| Growth Disorders | 1 | 2011 | 63 | 0.100 |
Why?
|
| Prenatal Diagnosis | 1 | 2012 | 110 | 0.100 |
Why?
|
| Electrophysiological Phenomena | 1 | 2011 | 51 | 0.100 |
Why?
|
| Evidence-Based Practice | 1 | 2011 | 47 | 0.090 |
Why?
|
| Pilot Projects | 4 | 2019 | 865 | 0.090 |
Why?
|
| Feasibility Studies | 4 | 2017 | 778 | 0.090 |
Why?
|
| Disease-Free Survival | 4 | 2018 | 1214 | 0.090 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2012 | 834 | 0.090 |
Why?
|
| Algorithms | 1 | 2019 | 1871 | 0.090 |
Why?
|
| Hydrocortisone | 1 | 2012 | 301 | 0.090 |
Why?
|
| Caregivers | 2 | 2020 | 159 | 0.090 |
Why?
|
| Myocarditis | 1 | 2011 | 51 | 0.090 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2011 | 101 | 0.090 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2010 | 41 | 0.090 |
Why?
|
| Documentation | 1 | 2011 | 103 | 0.090 |
Why?
|
| Renal Circulation | 1 | 2010 | 48 | 0.090 |
Why?
|
| Practice Guidelines as Topic | 3 | 2013 | 1040 | 0.090 |
Why?
|
| Parents | 1 | 2013 | 285 | 0.090 |
Why?
|
| Exercise Tolerance | 1 | 2010 | 52 | 0.090 |
Why?
|
| Texas | 2 | 2020 | 113 | 0.090 |
Why?
|
| Circadian Rhythm | 1 | 2012 | 304 | 0.090 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 2009 | 28 | 0.090 |
Why?
|
| Epidemiologic Methods | 1 | 2009 | 60 | 0.090 |
Why?
|
| Psychomotor Performance | 1 | 2013 | 496 | 0.090 |
Why?
|
| Drug Eruptions | 1 | 2009 | 34 | 0.080 |
Why?
|
| Diffusion of Innovation | 1 | 2009 | 71 | 0.080 |
Why?
|
| Spectrophotometry, Infrared | 1 | 2009 | 18 | 0.080 |
Why?
|
| Oxyhemoglobins | 1 | 2009 | 30 | 0.080 |
Why?
|
| Venous Thromboembolism | 1 | 2011 | 159 | 0.080 |
Why?
|
| Sensitivity and Specificity | 2 | 2014 | 2014 | 0.080 |
Why?
|
| Patient Selection | 1 | 2012 | 682 | 0.080 |
Why?
|
| Mitral Valve Stenosis | 1 | 2008 | 38 | 0.080 |
Why?
|
| Exercise Test | 1 | 2009 | 165 | 0.080 |
Why?
|
| Protein-Losing Enteropathies | 1 | 2007 | 6 | 0.080 |
Why?
|
| Severity of Illness Index | 4 | 2019 | 1837 | 0.080 |
Why?
|
| Drug Administration Schedule | 1 | 2009 | 894 | 0.080 |
Why?
|
| Ventricular Dysfunction | 1 | 2007 | 28 | 0.070 |
Why?
|
| Multiple Organ Failure | 2 | 2023 | 53 | 0.070 |
Why?
|
| Heart Rupture | 1 | 2007 | 9 | 0.070 |
Why?
|
| Adaptation, Psychological | 1 | 2008 | 166 | 0.070 |
Why?
|
| Papillary Muscles | 1 | 2007 | 17 | 0.070 |
Why?
|
| Reference Values | 2 | 2010 | 661 | 0.070 |
Why?
|
| Stroke Volume | 3 | 2021 | 461 | 0.070 |
Why?
|
| Blood Platelets | 1 | 2007 | 150 | 0.070 |
Why?
|
| Health Care Surveys | 1 | 2007 | 280 | 0.070 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 1 | 2006 | 18 | 0.070 |
Why?
|
| Infant, Premature | 2 | 2020 | 295 | 0.070 |
Why?
|
| Aortic Valve | 1 | 2008 | 243 | 0.070 |
Why?
|
| Rabies virus | 1 | 2005 | 5 | 0.060 |
Why?
|
| Rabies | 1 | 2005 | 7 | 0.060 |
Why?
|
| Lung Diseases | 1 | 2007 | 269 | 0.060 |
Why?
|
| Ketamine | 1 | 2005 | 25 | 0.060 |
Why?
|
| Antibodies | 1 | 2007 | 353 | 0.060 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2007 | 113 | 0.060 |
Why?
|
| Coma | 1 | 2005 | 47 | 0.060 |
Why?
|
| Anesthetics | 1 | 2005 | 53 | 0.060 |
Why?
|
| Reproducibility of Results | 3 | 2019 | 2752 | 0.060 |
Why?
|
| Cardiovascular System | 1 | 2005 | 62 | 0.060 |
Why?
|
| Ligation | 2 | 2014 | 51 | 0.060 |
Why?
|
| Biomarkers | 1 | 2010 | 1754 | 0.060 |
Why?
|
| Risk Management | 1 | 2003 | 42 | 0.060 |
Why?
|
| Program Development | 1 | 2003 | 123 | 0.050 |
Why?
|
| Mycoplasma hominis | 1 | 2002 | 1 | 0.050 |
Why?
|
| Ureaplasma | 1 | 2002 | 4 | 0.050 |
Why?
|
| Ureaplasma Infections | 1 | 2002 | 3 | 0.050 |
Why?
|
| Brain Abscess | 1 | 2002 | 8 | 0.050 |
Why?
|
| Opioid-Related Disorders | 1 | 2006 | 184 | 0.050 |
Why?
|
| Mycoplasma Infections | 1 | 2002 | 9 | 0.050 |
Why?
|
| Prosthesis Design | 2 | 2014 | 296 | 0.050 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2002 | 111 | 0.050 |
Why?
|
| Electroencephalography | 1 | 2006 | 749 | 0.050 |
Why?
|
| Antiviral Agents | 1 | 2005 | 475 | 0.050 |
Why?
|
| Blood Volume | 1 | 2021 | 49 | 0.050 |
Why?
|
| Disease Progression | 1 | 2006 | 1484 | 0.050 |
Why?
|
| Arteries | 2 | 2017 | 180 | 0.050 |
Why?
|
| Regional Blood Flow | 2 | 2013 | 198 | 0.050 |
Why?
|
| Hypoxia, Brain | 1 | 2021 | 43 | 0.050 |
Why?
|
| Embryonic and Fetal Development | 1 | 2001 | 72 | 0.050 |
Why?
|
| Vascular Surgical Procedures | 2 | 2013 | 149 | 0.050 |
Why?
|
| Alkalosis | 1 | 2000 | 10 | 0.050 |
Why?
|
| Airway Extubation | 1 | 2020 | 13 | 0.050 |
Why?
|
| Acidosis | 1 | 2000 | 55 | 0.050 |
Why?
|
| Transitional Care | 1 | 2020 | 18 | 0.050 |
Why?
|
| Vasodilation | 1 | 2000 | 93 | 0.050 |
Why?
|
| Ventricular Function, Right | 2 | 2014 | 146 | 0.040 |
Why?
|
| American Heart Association | 1 | 2020 | 93 | 0.040 |
Why?
|
| Hypertension, Pulmonary | 2 | 2001 | 352 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2014 | 374 | 0.040 |
Why?
|
| Checklist | 1 | 2020 | 61 | 0.040 |
Why?
|
| Antidiuretic Agents | 1 | 2019 | 3 | 0.040 |
Why?
|
| Fetus | 1 | 2001 | 231 | 0.040 |
Why?
|
| Quality of Life | 1 | 2008 | 1662 | 0.040 |
Why?
|
| Language Development | 1 | 2019 | 24 | 0.040 |
Why?
|
| Reflex, Pupillary | 1 | 2019 | 8 | 0.040 |
Why?
|
| Diagnosis-Related Groups | 1 | 2019 | 21 | 0.040 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 1999 | 31 | 0.040 |
Why?
|
| Hospitals | 1 | 2021 | 299 | 0.040 |
Why?
|
| Thinness | 1 | 2019 | 44 | 0.040 |
Why?
|
| Cost Savings | 1 | 2019 | 69 | 0.040 |
Why?
|
| Infusions, Intravenous | 1 | 2019 | 434 | 0.040 |
Why?
|
| Hospital Costs | 1 | 2019 | 107 | 0.040 |
Why?
|
| Myocardium | 1 | 2021 | 571 | 0.040 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2018 | 98 | 0.040 |
Why?
|
| Case-Control Studies | 2 | 2015 | 1852 | 0.040 |
Why?
|
| Education, Medical, Graduate | 1 | 2022 | 390 | 0.040 |
Why?
|
| Quality Indicators, Health Care | 1 | 2019 | 146 | 0.040 |
Why?
|
| Benchmarking | 1 | 2017 | 79 | 0.040 |
Why?
|
| Curriculum | 1 | 2022 | 567 | 0.040 |
Why?
|
| Communication | 1 | 2020 | 457 | 0.030 |
Why?
|
| Interviews as Topic | 1 | 2018 | 334 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2019 | 461 | 0.030 |
Why?
|
| Certification | 1 | 2016 | 61 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2017 | 299 | 0.030 |
Why?
|
| Pulsatile Flow | 1 | 2016 | 50 | 0.030 |
Why?
|
| Feeding Methods | 1 | 2015 | 1 | 0.030 |
Why?
|
| Blood Coagulation Tests | 1 | 2015 | 35 | 0.030 |
Why?
|
| Aortic Coarctation | 1 | 2015 | 36 | 0.030 |
Why?
|
| Bronchoscopy | 1 | 2017 | 159 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2019 | 1939 | 0.030 |
Why?
|
| Seizures | 1 | 2018 | 306 | 0.030 |
Why?
|
| Thrombosis | 1 | 2018 | 302 | 0.030 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2015 | 79 | 0.030 |
Why?
|
| Dysphonia | 1 | 2014 | 5 | 0.030 |
Why?
|
| Work of Breathing | 1 | 2014 | 5 | 0.030 |
Why?
|
| Recurrent Laryngeal Nerve Injuries | 1 | 2014 | 17 | 0.030 |
Why?
|
| Patient Safety | 1 | 2017 | 216 | 0.030 |
Why?
|
| Respiratory Sounds | 1 | 2014 | 34 | 0.030 |
Why?
|
| Hospital Charges | 1 | 2014 | 29 | 0.030 |
Why?
|
| Laryngoscopy | 1 | 2014 | 45 | 0.030 |
Why?
|
| Iatrogenic Disease | 1 | 2014 | 70 | 0.030 |
Why?
|
| Lung | 1 | 2000 | 1258 | 0.030 |
Why?
|
| Polytetrafluoroethylene | 1 | 2013 | 74 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2015 | 1011 | 0.030 |
Why?
|
| Cost of Illness | 1 | 2014 | 147 | 0.030 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2016 | 223 | 0.030 |
Why?
|
| Aorta, Thoracic | 1 | 2014 | 166 | 0.030 |
Why?
|
| Deglutition Disorders | 1 | 2014 | 119 | 0.030 |
Why?
|
| Coronary Circulation | 1 | 2013 | 131 | 0.030 |
Why?
|
| Data Collection | 1 | 2014 | 375 | 0.030 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2012 | 69 | 0.030 |
Why?
|
| Prevalence | 1 | 2016 | 1240 | 0.030 |
Why?
|
| Canada | 1 | 2012 | 208 | 0.020 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2013 | 242 | 0.020 |
Why?
|
| Ultrasonography, Doppler | 1 | 2012 | 85 | 0.020 |
Why?
|
| Body Surface Area | 1 | 2011 | 36 | 0.020 |
Why?
|
| Clinical Competence | 1 | 2016 | 780 | 0.020 |
Why?
|
| Echocardiography, Doppler | 1 | 2012 | 186 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 2012 | 229 | 0.020 |
Why?
|
| Aldosterone | 1 | 2010 | 56 | 0.020 |
Why?
|
| Intention to Treat Analysis | 1 | 2010 | 69 | 0.020 |
Why?
|
| Technology Transfer | 1 | 2009 | 3 | 0.020 |
Why?
|
| Adaptation, Physiological | 1 | 2012 | 314 | 0.020 |
Why?
|
| Organizational Innovation | 1 | 2009 | 41 | 0.020 |
Why?
|
| Shock, Cardiogenic | 1 | 2011 | 106 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2010 | 275 | 0.020 |
Why?
|
| Cardiac Care Facilities | 1 | 2008 | 2 | 0.020 |
Why?
|
| Antihypertensive Agents | 1 | 2010 | 249 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 2010 | 433 | 0.020 |
Why?
|
| Child Welfare | 1 | 2008 | 38 | 0.020 |
Why?
|
| Cardiomyopathies | 1 | 2011 | 263 | 0.020 |
Why?
|
| Leadership | 1 | 2009 | 138 | 0.020 |
Why?
|
| Animals | 3 | 2005 | 27280 | 0.020 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2008 | 103 | 0.020 |
Why?
|
| Phenotype | 1 | 2014 | 2439 | 0.020 |
Why?
|
| Platelet Factor 4 | 1 | 2007 | 12 | 0.020 |
Why?
|
| Replantation | 1 | 2007 | 36 | 0.020 |
Why?
|
| Risk | 1 | 2008 | 657 | 0.020 |
Why?
|
| Psychometrics | 1 | 2008 | 329 | 0.020 |
Why?
|
| Thrombocytopenia | 1 | 2007 | 187 | 0.020 |
Why?
|
| Dysarthria | 1 | 2005 | 6 | 0.020 |
Why?
|
| Athetosis | 1 | 2005 | 4 | 0.020 |
Why?
|
| Amantadine | 1 | 2005 | 18 | 0.020 |
Why?
|
| Bites and Stings | 1 | 2005 | 9 | 0.020 |
Why?
|
| Chorea | 1 | 2005 | 12 | 0.020 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2005 | 16 | 0.020 |
Why?
|
| Midazolam | 1 | 2005 | 48 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2014 | 2334 | 0.020 |
Why?
|
| Ribavirin | 1 | 2005 | 40 | 0.020 |
Why?
|
| Indicator Dilution Techniques | 1 | 2005 | 9 | 0.020 |
Why?
|
| Calorimetry, Indirect | 1 | 2005 | 14 | 0.020 |
Why?
|
| Motor Skills | 1 | 2005 | 79 | 0.020 |
Why?
|
| Benzodiazepines | 1 | 2005 | 67 | 0.020 |
Why?
|
| Reflex | 1 | 2005 | 80 | 0.020 |
Why?
|
| Shock | 1 | 2005 | 44 | 0.020 |
Why?
|
| Respiratory Function Tests | 1 | 2005 | 139 | 0.020 |
Why?
|
| Electric Impedance | 1 | 2005 | 110 | 0.010 |
Why?
|
| Research Design | 1 | 2008 | 597 | 0.010 |
Why?
|
| Infant Welfare | 1 | 2004 | 6 | 0.010 |
Why?
|
| Pregnancy | 1 | 2012 | 3006 | 0.010 |
Why?
|
| Chiroptera | 1 | 2005 | 53 | 0.010 |
Why?
|
| Oxygenators | 1 | 2004 | 3 | 0.010 |
Why?
|
| Cell Respiration | 1 | 2004 | 18 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2009 | 1702 | 0.010 |
Why?
|
| Sampling Studies | 1 | 2004 | 72 | 0.010 |
Why?
|
| Veins | 1 | 2004 | 95 | 0.010 |
Why?
|
| Pain | 1 | 2006 | 400 | 0.010 |
Why?
|
| Hypothermia, Induced | 1 | 2004 | 82 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2004 | 234 | 0.010 |
Why?
|
| Monitoring, Intraoperative | 1 | 2004 | 110 | 0.010 |
Why?
|
| Doxycycline | 1 | 2002 | 28 | 0.010 |
Why?
|
| Perfusion | 1 | 2004 | 234 | 0.010 |
Why?
|
| Heart Arrest, Induced | 1 | 2002 | 30 | 0.010 |
Why?
|
| Immunoglobulin E | 1 | 2002 | 145 | 0.010 |
Why?
|
| Models, Cardiovascular | 1 | 2002 | 104 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2004 | 901 | 0.010 |
Why?
|
| Hypercapnia | 1 | 2000 | 44 | 0.010 |
Why?
|
| Endothelium | 1 | 2000 | 58 | 0.010 |
Why?
|
| Acetylcholine | 1 | 2000 | 177 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2004 | 1709 | 0.010 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2002 | 343 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2004 | 898 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2007 | 2609 | 0.010 |
Why?
|
| Blood Circulation | 1 | 1999 | 30 | 0.010 |
Why?
|
| Nitric Oxide | 1 | 2000 | 279 | 0.010 |
Why?
|
| Swine | 1 | 2000 | 581 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2002 | 784 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2000 | 2350 | 0.010 |
Why?
|
| Middle Aged | 1 | 2011 | 25826 | 0.010 |
Why?
|